Kazuko Suzuki

Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetes

Kazuko Suzuki, Tatsuo Yanagawa, Toshiaki Shibasaki et al. · Diabetes Research and Clinical Practice · 2005 · 79 citations

Medicine, Pharmacokinetics, Pharmacology +12

Genetic Variations and Haplotypes of CYP2C19 in a Japanese Population

Hiromi Fukushima‐Uesaka, Yoshiro Saito, Keiko Maekawa et al. · Drug Metabolism and Pharmacokinetics · 2005 · 78 citations

Life Sciences, Genetics, Molecular Genetics +11

Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region.

Kazuko Suzuki, M Kuriyama, Tetsuo Saito et al. · Journal of Clinical Investigation · 1997 · 71 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese

Keiko Maekawa, Hiromi Fukushima‐Uesaka, Masahiro Tohkin et al. · Pharmacogenetics and Genomics · 2006 · 67 citations

Life Sciences, Genetics, Pharmacology +13

Blood Pressure, Proteinuria, and Renal Function Decline: Associations in a Large Community-Based Population

Atsushi Hirayama, Tsuneo Konta, Keita Kamei et al. · American Journal of Hypertension · 2015 · 67 citations · Full text

Medicine, Nephrology, Pediatric Nephrology +16